Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Oxford Biomedica PLC - Filing #5242757

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
45,976,000 GBP
19 ,880 GBP
Revenue
139, 989 GBP
142,797,000 GBP
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
12, 615 GBP
25, 455 GBP
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
56,462,000 GBP
9 , 461 GBP
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
98,622,000 GBP
46,207,000 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.